Certificate library
Semaglutide Certificate of Analysis
- Ozcanium
- 98.89%
- Independent · 7 Sept 2026
- Current batch
- 98.86%
- APL-SEMA10-2608-01
- Batches published
- 1
- Measured purity
- 98.86%
- Most recent analysis
- 31 August 2026
Independent verification
Semaglutide is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 98.89% purity by UPLC-MS/MS, analysed 7 September 2026 on lot APL-SEMA10-2609-01, net content 9.75 mg, verification code OZ-HPLCMS-TP98; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 8 September 2026, verification code OZ-ENDOTX-TEP2.
Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.
- Third-Party Purity COA (PDF, opens in a new tab)98.89% purity by UPLC-MS/MS · net content 9.75 mg
- Third-Party Endotoxin Test (PDF, opens in a new tab)Bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL
Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.
Semaglutide is independently verified by Ozcanium Analytics at 98.89% purity by UPLC-MS/MS, analysed 7 September 2026. Every batch of Semaglutide is also assayed in our own laboratory before it is released. Purity is measured by HPLC / Mass Spectrometry on the PDA 214 nm channel, reported as main-peak area against every integrated impurity peak. Molecular identity is confirmed by LC-MS across 3 monitored ion channels. The release specification is ≥98.0%. Across the 1 batch published here, measured purity was 98.86%.
Current batch — APL-SEMA10-2608-01
View the full certificate- Document ID
- APL-COA-SEMA10-2608-01
- Net content
- 10.09 mg
- Tested
- 31 August 2026
- Method
- HPLC / Mass Spectrometry
| Test | Specification | Result | Status |
|---|---|---|---|
| Appearance | White/Off-White Lyophilised Powder | Conforms | PASS |
| Identity (MS) | Confirmed | Confirmed | PASS |
| Purity (HPLC) | ≥98.0% | 98.86% | PASS |
| Peptide Content | 95–105% | 98.4% | PASS |
| Endotoxins | <0.5 EU/mg | <0.20 EU/mg | PASS |
| # | Time (min) | Area | % Area | Identification |
|---|---|---|---|---|
| 1 | 4.110 | 22,320 | 0.310 | — |
| 2 | 4.380 | 33,840 | 0.470 | — |
| 3 | 4.620 | 7,117,920 | 98.860 | Semaglutide |
| 4 | 5.040 | 18,720 | 0.260 | — |
| 5 | 6.710 | 7,200 | 0.100 | — |
| Monitored (m/z) | Detected (m/z) | Intensity |
|---|---|---|
| 824 | 823.75 | 1.3 |
| 1029 | 1029.43 | 2.05 |
| 1372 | 1372.24 | 1.15 |
Semaglutide
Intensity ×107
Every published Semaglutide batch
Match the batch number printed on your vial to open its certificate.
| Batch | Size | Tested | Purity | Certificate |
|---|---|---|---|---|
| APL-SEMA10-2608-01 | 10 mg | 31 August 2026 | 98.86% | View |
Semaglutide testing — common questions
- Is Semaglutide third-party tested?
- Yes. Semaglutide is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 98.89% purity by UPLC-MS/MS, analysed 7 September 2026 on lot APL-SEMA10-2609-01, net content 9.75 mg, verification code OZ-HPLCMS-TP98; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 8 September 2026, verification code OZ-ENDOTX-TEP2. Both reports are published on this page as the laboratory issued them, and each verification code can be redeemed in the lab's own portal so the document is confirmed against their records rather than ours. Every batch of Semaglutide is also analysed in our own laboratory and published here in full.
- What purity is the current batch of Semaglutide?
- Ozcanium Analytics, an independent Australian laboratory, measured Semaglutide at 98.89% by UPLC-MS/MS on 7 September 2026. In our own laboratory, batch APL-SEMA10-2608-01, the batch currently shipping, measured 98.86% by HPLC / Mass Spectrometry, tested 31 August 2026. The release specification is ≥98.0%. Across the 1 batch published here, measured purity was 98.86%.
- How do I find the certificate for the Semaglutide vial I have?
- Each certificate reports one production batch, so match the batch number printed on your vial against the batch history on this page rather than against the compound in general. 1 batch is published: APL-SEMA10-2608-01. If the batch you hold isn't listed, email [email protected] with the compound and batch number and we'll send the document.
- What is Semaglutide tested for?
- Every batch is tested for Appearance, Identity (MS), Purity (HPLC), Peptide Content and Endotoxins. Each result is printed beside a fixed specification — ≥98.0% for purity, set as house policy rather than per batch, so a batch cannot pass by having its target moved. Molecular identity is confirmed by LC-MS across 3 monitored ion channels.
Semaglutide identification
The registry identifiers printed on every Semaglutide certificate. They are what lets the compound be checked against a public record independently of anything we assert about it.
- CAS Number
- 910463-68-2
- Molecular Formula
- C187H291N45O59
- Molecular Weight
- 4113.58 g/mol
- Form
- Lyophilised Powder
- Presentation
- 10 mg
Sequence
His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEA-AEEA-gamma-Glu-C18 diacid)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-GlyNext
Holding a Semaglutide batch that isn't listed above? Email [email protected] with the batch number and we'll send the document. For the analytical method behind these figures, see our guide to HPLC in peptide quality control.
All products are supplied for laboratory research use only. They are not therapeutic goods and are not for human or veterinary use.